Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1588303

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1588303

Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Endoscopy, Blood Test), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Gastrointestinal Diagnostics Market Growth & Trends:

The global gastrointestinal diagnostics market size is expected to reach USD 6.56 billion by 2030, registering a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness about gastrointestinal disorders and a surge in gastrointestinal disorder testing are the major factors driving the market. Moreover, technological advancements in gastrointestinal infection testing are expected to cater to the market demand. For instance, in May 2022, QIAGEN launched QIAstat-Dx Rise, which is capable of providing results in a span of one hour for multiple diseases.

The increasing trend of a sedentary lifestyle, lack of exercise, unhealthy eating habits, and a higher prevalence of obesity are anticipated to fuel GI diagnostics market growth. According to the CDC, the prevalence of obesity among people in the U.S. is between 30-40%. States such as Alabama, Alaska, and Arizona have the highest prevalence of obesity in the U.S. Obesity is associated with GI diseases such as gastroesophageal reflux disease, diarrhea, gastric cancer, and others. Hence, it is expected to impetus market growth.

Technological advancements associated with gastrointestinal diagnostics for early diagnosis and efficient testing are expected to augment market growth during the forecast period. For instance, in March 2022, Luminex Corporation obtained a CE mark for its NxTAGxMAP GI Pathogen Panel. This test is a detailed multiplex test that detects nucleic acids from the 16 most clinically relevant viral, parasitic, and bacterial pathogens in stool samples. Moreover, the test is capable of providing results on the same day and can run 96 samples at a time.

Moreover, the presence of organizations involved in increasing awareness regarding gastrointestinal disorders is expected to facilitate market expansion. For instance, organizations such as the Gastrointestinal Society (Canadian Society of Intestinal Research) and the International Foundation for Gastrointestinal Disorders are actively involved in promoting gastrointestinal health and broadening the understanding of GI disorders, thereby augmenting market growth.

Furthermore, various strategic initiatives undertaken by market players to strengthen their product portfolio and expand global footprints are likely to provide lucrative growth opportunities for the market. For instance, in November 2021, The Life Raft Group and Bayer Pharmaceuticals announced a research collaboration for broadening access to genomic testing for GI stromal tumor patients. The aim of this collaboration is to advance precision medicine and improve genetic testing to identify patients in the U.S.

In addition, in June 2021, Prometheus Laboratories, Inc. announced an agreement with MultiPlan for accessing specialized gastrointestinal testing. Prometheus offered its breakthrough testing solutions to improve the outcome of GI disorders. This agreement has allowed the testing service of Prometheus to reach the maximum number of customers.

Gastrointestinal Diagnostics Market Report Highlights:

  • On the basis of test type, the endoscopy segment held the largest share in 2024 owing to rising demand for minimally invasive procedures
  • Based on technology, the PCR accounted for the second-largest share in 2024 due to the availability of a robust product portfolio and rising product launches
  • The infection application segment held the largest share in 2024 owing to the higher incidence of GI infections and the surge in awareness
  • On the basis of test location, the central laboratories segment held the largest share in 2024. The point-of-care segment is anticipated to register the fastest growth rate throughout the forecast period
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing research activities in the region
Product Code: GVR-4-68039-988-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Type
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. Test location outlook
  • 2.3. Competitive Insights

Chapter 3. Gastrointestinal Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of substance abuse
      • 3.2.1.2. Increase in prevalence of Gastrointestinal disorders
      • 3.2.1.3. Technological advancements pertaining to GI diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent rules and regulations for GI diagnostic procedures
  • 3.3. Gastrointestinal Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Gastrointestinal Diagnostics Market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Gastrointestinal Diagnostics Market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Endoscopy
      • 4.4.1.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Blood Test
      • 4.4.2.1. Blood Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. H. Pylori Test
      • 4.4.3.1. H. Pylori Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Calprotectin Test
      • 4.4.4.1. Calprotectin Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Immunoglobulin A Test
      • 4.4.5.1. Immunoglobulin A Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Gastrointestinal Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Gastrointestinal Diagnostics Market by Technology Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. PCR
      • 5.4.1.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Microbiology
      • 5.4.2.1. Microbiology market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. ELISA
      • 5.4.3.1. ELISA market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Gastrointestinal Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Gastrointestinal Diagnostics Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Infection
      • 6.4.1.1. Infection market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Inflammatory Bowel Disease
      • 6.4.2.1. Inflammatory Bowel Disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Gastroesophageal Reflux Disease
      • 6.4.3.1. Gastroesophageal reflux disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Cancer
      • 6.4.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Gastrointestinal Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Test Location Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Gastrointestinal Diagnostics Market by Test Location Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Central Laboratories
      • 7.4.1.1. Central Laboratories market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. Point-of-Care
      • 7.4.2.1. Point-of-Care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Gastrointestinal Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2024
    • 9.3.2. BIOMERIEUX
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. F. Hoffmann-La Roche Ltd.
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Abbott
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Beckman Coulter, Inc.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Siemens Healthineers AG
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. DiaSorin S.p.A
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. QIAGEN
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Meridian Bioscience
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Hologic, Inc.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
Product Code: GVR-4-68039-988-6

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of abbreviation
  • Table 3 North America gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 5 North America gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 8 U.S. gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 9 U.S. gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 12 Canada gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Canada gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 16 Mexico gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Mexico gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Mexico gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 20 Europe gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Europe gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Europe gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 25 Germany gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Germany gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 29 UK gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 30 UK gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 33 France gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 34 France gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 France gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 France gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 37 Italy gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Italy gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Italy gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 41 Spain gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 42 Spain gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Spain gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 45 Denmark gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 46 Denmark gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 49 Sweden gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 50 Sweden gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Sweden gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 53 Norway gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Norway gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Norway gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 62 China gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 63 China gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 China gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 China gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 66 Japan gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Japan gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 70 India gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 71 India gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 India gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 73 India gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 74 South Korea gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 75 South Korea gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 78 Australia gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 79 Australia gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 82 Thailand gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 83 Thailand gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Thailand gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 86 Latin America gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 87 Latin America gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Latin America gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Latin America gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 90 Brazil gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 91 Brazil gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Brazil gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 93 Brazil gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 94 Argentina gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 95 Argentina gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Argentina gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 98 MEA gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 99 MEA gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 100 MEA gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 MEA gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 MEA gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 103 South Africa gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 104 South Africa gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 111 UAE gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 112 UAE gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 113 UAE gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 115 Kuwait gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Kuwait gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Gastrointestinal Diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Gastrointestinal Diagnostics market: Test Type movement analysis
  • Fig. 12 Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Blood test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 H. pylori test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Calprotectin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Immunoglobulin A test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Gastrointestinal Diagnostics market: Technology movement Analysis
  • Fig. 19 ELISA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Microbiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Gastrointestinal Diagnostics market: Application movement analysis
  • Fig. 24 Infection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Inflammatory Bowel Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Gastroesophageal Reflux Disease (GERD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Gastrointestinal Diagnostics market: Test Location movement analysis
  • Fig. 30 Central laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Point-of-Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Market share of key market players- gastrointestinal diagnostics market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!